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Introduction

Doxorubicin Treatments

It was predicted that the treated cell lines would exhibit resistance to cell dosage.
Meaning, the 2.5 µM cell line should have shown enhanced survival in comparison
to the other cells when treated with 2.5 µM doxorubicin. However, the data has
shown that in all dosage treatments, the wildtype cells survived more than the
treated cell lines. Because this assay was also performed only once, a conclusion
cannot be made with this data. However, this experiment suggests that the treated
cell lines, though not drug-resistant, were more weakened to the cell treatment,
meaning the treated cell lines were more affected by the drug in comparison to
wildtype.

There are two types of metabolic pathways utilized to obtain energy: anaerobic
glycolysis and oxidative phosphorylation. In anaerobic glycolysis, the start molecule is
glucose, and the end product is lactic acid. Oxidative phosphorylation also starts with
glucose, but converts it into pyruvate, which then enters the tricarboxylic acid cycle,
followed by the electron transport chain. Cancer cells prefer to use anaerobic
glycolysis as their means of obtaining energy, even in the presence of oxygen. This
phenomenon is known as the Warburg effect, where cancer cells go through aerobic
glycolysis—following the anaerobic glycolysis pathway even in the presence of
oxygen. By utilizing anaerobic glycolysis, cancer cells are able to obtain energy much
faster as opposed to when using aerobic glycolysis, which explains a tumor’s capability
of proliferating at a rapid pace.2

Discussion
!

Chemotherapy is one method of treating cancer, but does not guarantee curing it, for
the treatment sometimes does not kill all the cells, which may cause the cancer to
regress. Understanding the change in metabolism of these drug-resistant cancer cells
provides a potential target for cancer treatment, with the possibility of curing cancer.
The goal of this study is to simulate dormancy in the MCF-7 cell line, a form of breast
cancer, and discover the key differences in its metabolism in comparison to the native
wildtype cells. In this study, doxorubicin was the chemotherapy drug utilized to create
drug-resistant MCF-7 cell lines, which prevents cell growth by proteolytically cleaving
cAMP responsive element binding protein 3-like 1 (CREB3L1), a transcription factor,
via the production of ceramide.3

Cell Culturing
Cells were grown in a T-75 flask with RPMI media containing 10% FBS and 1%
penicillin/strep, and stored in an incubator under 37°C. Cells that were to be treated
with drug were trypsinized and transferred to 25-cm small plates. Doxorubicin was
dosed in concentrations of 1 µM, 2 µM, 2.5 µM, 3 µM, 4 µM, and 5 µM. Cell cultures
were refreshed with new RPMI media whenever the media (originally orange) turned
yellow, an indicator that the cell culture had consumed all of the nutrients in the media
and that the culture was slowly becoming acidic. When the confluency of the small
plates was full, meaning, when the surface of the plate was covered with cells, and
there were no empty spaces, 1 mL of trypsin was used to loosen cells from the plate
surface. To neutralize the trypsin, 4 mL of RPMI media was used. 1 mL of the total
solution was then passed to a new small plate, with an additional 4 mL of RPMI media
to continue the culture at 20% plate confluency. In T-75 flasks, dosed cultures that
were stable in confluency for three days were scraped, collected, and frozen for future
use for the MTT assay.

Figure 2: Morphology observations of doxorubicin-treated MCF-7 cells. 1: Wildtype MCF-7 cell line.
2: 1 µM Doxorubicin-treated MCF-7 cell line. 3: 2.5 µM Doxorubicin-treated MCF-7 cell line. 4: 5 µM
Doxorubicin-treated MCF-7 cell line. 5. 10 µM Doxorubicin-treated MCF-7 cell line.
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Based on Figure 2, the treatments showed that doses higher than 5uM were too
strong to create drug-resistant cancer cell lines, as all of the cells died at a
concentration of 10 µM. However, doxorubicin doses of 1uM and 2.5uM caused the
cells to exhibit a morphology change. As opposed to the more rounded shape of
MCF-7 cells in wildtype form, cells treated with concentrations of either 1uM or 2.5uM
became more elongated and thinner at the ends, while the middle of the cells
remained round. We believe that this change in morphology is what allows MCF-7
cells to adapt in the presence of doxorubicin, so that they have a higher chance of
staying alive.

MTT Assay
MTT Assay was conducted to test for the toxicity and therefore viability of the cell
b
lines as followed by a protocol from Waller and Provost Lab. This assay involves
reducing 30(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (yellow MTT)
to a purple formazon in the mitochondria of alive cells. Mitochondrial dehydrogenases
cleave the tetrazolium ring in the mitochondria in order create purple MTT formazan
crystals, which are insoluble without the addition of another solvent. DMSO was used
to solubilize the formazan crystals.

This study was conducted for ten weeks; for three of those ten weeks, there was a
contamination problem in the cell incubator, thus compromising most cells with yeast
growth. Due to this contamination issue and the limited amount of time to conduct
research, it was difficult to maintain growth of MCF-7 cells, and observe the
confluency trend of treated cells. This issue was resolved towards the last two weeks
of research. The figures shown in this report reflect data from MCF-7 cells that were
uncontaminated. Due to the contamination, there was a lack of several viable cell
lines available for analysis and documentation in this report
We plan to continue treating MCF-7 cells with doxorubicin in order to create drugresistant cells and find a more concrete dosage range of which doxorubicin can be
used to create said cell lines, as well as confirm the findings from the MTT assay,
which suggest the cell lines made were not resistant, only weakened. These cell
lines will then be measured via oxygen electrode in order to further analyze the
mitochondria activity of these cells by measuring the amount of aerobic respiration,
and to compare them to wildtype MCF-7 cells. Future MTT assays will be done with
cell lines that have had stable confluency for a longer period of time longer than
three days. When it is confirmed through MTT assays and the oxygen electrode that
drug resistant cell lines were successfully created, cells will then be analyzed by
electron microscope in order to obtain a more accurate visual in terms of
morphological changes in MCF-7 cells. From there, we intend to discover the same
findings with another drug, cyclophosphamide, in order to see if different
chemotherapy agents would require different concentrations to make MCF-7 cells
drug resistant, as well as if similar or different morphological changes can be
observed.

Table 1: Setup of the 96-well plate for the MTT assay.
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Figure 1: A time-progressive graph of the confluency
of MCF-7 cells treated with 2.5 µM Doxorubicin
!

Treated cells were considered to be drug-resistant if its cell confluency initially
declined, but then stabilized at a lower percentage. We refer to this stage as
“dormancy”. We discovered that doxorubicin was most effective in achieving
dormancy with a concentration range of 2uM – 3 µM, although cells tended to
die off approximately a week after initial treatment. Figure 1 showed the
progress in confluency of one of the cell treatments, with 2.5 µM doxorubicin.
During the weekends, confluency was not recorded. This cell line was used in
the MTT assay conducted for this study. Cells were hard to maintain because it
was difficult to predict if cells would proliferate or die. The data obtained from the
treated cells could not explain the MCF-7 cell line’s behavior in the presence of
doxorubicin. However, it had been noticed that if drug treatment was started at a
high confluency, it would take much longer before the cells began to show a
decline in cell population.

Figure 3: Results from the MTT assay.

The setup for the MTT assay is shown in Table 1. Using a 96-well plate, 36 wells
were used in the assay to test 2.5 µM and 5.0 µM doxorubicin-treated cells in order to
determine whether or not the treated cells were drug resistant. Along with a control,
each type of cell line was tested in triplicates. The three cell lines were given four
different types of treatments: control, 2.5 µM, 5 µM, and 10 µM doxorubicin. Each well
was aimed to have 2,500 cells/mL, and contained a volume of 200 uL. After setting up
the well plate, cells were given one day to acclimate to the new environment before
treating with various concentrations of doxorubicin. Once cells were incubated for
another day, 20 mL of 5 g/mL thiazolyl blue tetrazolium bromide (MTT solution) was
added to each well. After ten minutes of gentle shaking, each well’s absorbance was
recorded via spectrophotometer at 600 nm.8
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